Targeting Inflammation in Atherosclerosis

Targeting inflammation in atherosclerosis is an emerging strategy to treat cardiovascular diseases. Atherosclerosis, the buildup of fatty plaques in arteries, is driven not only by cholesterol but also by chronic inflammation. Inflammatory cells, such as macrophages, infiltrate plaque sites and exacerbate plaque formation, making it unstable and prone to rupture, which can lead to heart attacks or strokes.

Recent research suggests that reducing inflammation could slow or even reverse atherosclerosis. Anti-inflammatory treatments aim to target key inflammatory pathways involved in plaque development. For instance, drugs like canakinumab, which inhibit the interleukin-1β (IL-1β) pathway, have shown promise in reducing inflammation and lowering cardiovascular events. Additionally, statins, commonly used to lower cholesterol, have anti-inflammatory effects that contribute to their cardiovascular benefits.

By focusing on inflammation, researchers are developing new therapies that may complement traditional treatments, providing a more comprehensive approach to preventing and managing atherosclerosis and its associated risks.

    Related Conference of Targeting Inflammation in Atherosclerosis

    November 25-26, 2024

    7th International Conference on Cardiovascular Diseases and Therapeutics

    Paris, France
    December 09-10, 2024

    3rd International Conference on Cardiology

    Dubai, UAE
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    December 12-13, 2024

    13th World Heart Congress

    Rome, Italy
    December 12-13, 2024

    5th Global Summit on Heart Congress

    Dubai, UAE
    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    February 24-25, 2025

    33rd International Conference on Cardiology and Cardiovascular Diseases

    London, UK
    February 27-28, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 23-24, 2025

    14th International Conference on Cardiology and Cardiovascular Medicine Research

    Paris, France
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 28-29, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    April 28-29, 2025

    37th World Congress on Cardiology & Heart Diseases

    Frankfurt, Germany
    May 14-15, 2025

    6th International Conference on Cardiac Imaging and Diagnostics

    Barcelona, Spain
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    June 12-13, 2025

    12th International Conference on Interventional Cardiology

    London, UK
    June 19-20, 2025

    12th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

    Paris, France
    July 21-22, 2025

    33rd International Congress on Cardiology and Medical Interventions

    Toronto, Canada
    August 21-22, 2025

    34th International Conference on Clinical and Experimental Cardiology Research

    Vancouver, Canada
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    October 22-23, 2025

    12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Aix-en-Provence, France

    Targeting Inflammation in Atherosclerosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in